The Vita Coco Company, Inc.'s SEC filings document financial results, operating updates, governance matters, and public-company disclosures for its beverage brand portfolio. Form 8-K reports include quarterly and annual results, guidance updates, Regulation FD disclosures, and other material events related to the company’s coconut water and better-for-you beverage operations.
Proxy materials describe annual meeting proposals, board structure, committee assignments, executive compensation, equity awards, and stockholder voting matters. Additional 8-K filings record director appointments, board retirements, officer roles, compensation arrangements, tariff-related disclosures, and the company’s capital-market reporting obligations as a Nasdaq-listed Delaware corporation.
Vita Coco Company, Inc.'s Chief Financial Officer Corey Baker reported a sequence of option exercises and stock sales. He exercised Non-Qualified Stock Options for 2,000 shares of Common Stock at an exercise price of $16.9100 per share, then sold 3,000 Common Stock shares at prices of $38.6600 and $40.0000 per share pursuant to a Rule 10b5-1 trading plan. Following these transactions, he directly holds 38,754 shares of Common Stock and 59,197 Non-Qualified Stock Options.
Michael Kirban, Executive Chairman and Director of Vita Coco Company, Inc. (COCO), reported a sale of common stock under a Rule 10b5-1 trading plan. On 09/11/2025 he disposed of 20,000 shares at a weighted average price of $39.045 (individual sale prices ranged from $39.00 to $39.19). After the reported transaction(s) the filing shows 1,579,049 shares beneficially owned indirectly by Mr. Kirban and additional holdings tied to the Michael Kirban Revocable Trust. The filing also discloses outstanding non-qualified stock options totaling 1,164,490 options across multiple grants with exercise prices ranging from $10.178 to $32.78 and varying vesting and expiration schedules. The sale was executed pursuant to a pre-established plan and the Form 4 was signed by an attorney-in-fact on 09/15/2025.
Vita Coco Company, Inc. (COCO) filed a Form 144 reporting insider transactions tied to the sale of common stock. The filing shows 1,000 shares to be sold through Morgan Stanley Smith Barney on 09/15/2025 with an aggregate market value of $39,570. It also discloses a contemporaneous acquisition: the filer exercised options and acquired those 1,000 shares on 09/15/2025 and paid in cash. The filing lists prior 10b5-1 sales by the same person totaling 6,000 shares executed between 09/05/2025 and 09/12/2025 with gross proceeds shown for each trade. The notice includes the required representation that the seller is unaware of undisclosed material adverse information.
Michael Kirban, Executive Chairman and director of The Vita Coco Company, Inc. (COCO), reported insider transactions on Form 4. The filing shows a sale of 30,000 shares of common stock on 09/09/2025 effected pursuant to a Rule 10b5-1 trading plan at a weighted average price of $39.161 per share. The form also records a disposition of 127,629 shares and reports post-transaction beneficial ownership figures including 1,599,049 shares indirectly beneficially owned by Mr. Kirban and 615,681 shares held indirectly by the Michael Kirban Revocable Trust. The filing discloses multiple outstanding non-qualified stock options with exercise prices from $10.178 to $32.78 and vesting schedules through 2036, several of which are fully vested and currently exercisable.
The filing reports insider sales by Corey Baker, Chief Financial Officer of Vita Coco Company, Inc. (COCO). Mr. Baker sold 1,000 shares on 09/09/2025 at $38.40 and 1,000 shares on 09/10/2025 at $38.16 under a Rule 10b5-1 trading plan, reducing his direct common stock holdings from 41,754 to 39,754 shares. The Form 4 also discloses outstanding non-qualified stock options exercisable into a total of 61,197 shares across five option grants with exercise prices ranging from $16.91 to $33.36 and various vesting schedules.
Corey Baker, Chief Financial Officer of Vita Coco Company, Inc. (COCO), reported two sales of common stock under a Rule 10b5-1 plan. The filings show a sale of 1,000 shares on 09/05/2025 at $38.00 and a sale of 1,000 shares on 09/08/2025 at $38.51, reducing his beneficially owned common stock to 41,754 shares. The report also lists outstanding non-qualified stock options exercisable into common stock: 14,205 shares at a $16.91 strike, 13,481 at $24.35, 8,746 at $26.18, 11,547 at $27.59 and 13,218 at $33.36, each held directly. Several option grants have scheduled vesting dates and installment vesting schedules as described by the reporting person.
The Vita Coco Company, Inc. (COCO) filed a Form 144 reporting a proposed sale of 50,000 common shares. The shares are to be sold through Morgan Stanley Smith Barney LLC with an approximate sale date of 09/09/2025 and an aggregate market value of $1,919,500. The filer acquired these shares as founders' shares on 09/10/2010. There are 56,822,981 shares outstanding per the form. The filing states no securities were sold by the filer in the past three months and includes the standard representation that the selling person does not possess undisclosed material adverse information.
The Vita Coco Company, Inc. (COCO) submitted a Form 144 reporting proposed and recent insider sales. The filer reported a proposed sale of 4,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $154,160, planned for 09/08/2025 on NASDAQ. Those 4,000 shares were acquired as restricted stock units on 03/10/2025. The filing also discloses a prior 10b5-1 sale of 1,000 shares by Corey Baker on 09/05/2025 generating $38,000 in gross proceeds. The notice includes the required attestation regarding material nonpublic information.
Vita Coco Company director Ira Liran reported sales of common stock under a Rule 10b5-1 trading plan. On 09/03/2025 he disposed of 14,734 shares at a weighted-average price of $37.052 per share and on 09/04/2025 he disposed of 2,114 shares at a weighted-average price of $37.001 per share, for a total of 16,848 shares sold. Following these transactions the filing shows 618,341 shares held directly and 782,579 shares held indirectly through the Ira Liran 2012 Family Trust. The filing was signed by Alison Klein, attorney-in-fact, on 09/05/2025.
Form 144 notice for The Vita Coco Company, Inc. (COCO) reports a proposed sale of 1,000 common shares through Morgan Stanley Smith Barney LLC on 09/05/2025 on NASDAQ with an aggregate market value of $37,250.00. The shares represent restricted stock units acquired from the issuer on 03/10/2025, with payment recorded on the same date. The filing indicates 56,822,981 shares outstanding for the class. No securities were reported sold by the same person in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information. Several filer and issuer identifying details (names, CIK, contact) are not provided in the visible content.